Recommended Reading

Bariatric News is teaming up with Medtronic for World Obesity Day on 4th March 2021 and asking you to join the global community to raise awareness of obesity as a chronic disease, its causes and consequences, and call for action for impr

Eiger BioPharmaceuticals has announced positive results from the Phase 2 PREVENT study of Avexitide in patients with severe Post-Bariatric Hypoglycaemia (PBH), the outcomes were published in Journal of Clinical Endocrinology & Metabolism (Craig, C.M.